EsoCap AG reports positive topline results from ACESO Phase II trial investigating ESO-101 in eosinophilic esophagitis (EoE)

Dec 6, 2023 | CFO-Services, Corporate Finance, H&P News

Great news! Our long-standing client EsoCap AG has unveiled impressive clinical data – another milestone on the road to groundbreaking advances in healthcare! We have proudly accompanied EsoCap as CFO partner since its inception and are thrilled to witness these...

Hoffmann & Partner AG is once again one of the best tax experts in Switzerland in 2024.

Nov 1, 2023 | CFO-Services, Corporate Finance, Tax

We are pleased that we are once again among the top tax experts & fiduciaries in Switzerland this year! For the fourth time, the market research institute Statista conducted a survey on behalf of BILANZ among several thousand industry professionals and clients in...

Hoffmann & Partner expands its service offering and wins a first mandate with Kuros Biosciences

Mar 1, 2023 | CFO-Services, Corporate Finance, M&A, Tax

With the most recent additions to our partnership and board, Hoffmann & Partner has extended their offering to include executive CFO services for listed clients including clients pursuing a listing to an international stock exchange. Further the company now...

Changes in the national tax law destroy one of the biggest advantages for start-ups

Jan 30, 2023 | CFO-Services, Corporate Finance, M&A, Tax

Employee Stock Ownership Plans (ESOPs) in Switzerland Employee options were an attractive financial instrument before the tax law was changed per 01.01.2021. Prior to the changes employees could exercise their options when the fair value of share prices was still low...